Autoimmune Diseases  >>  Byetta (exenatide)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Byetta (exenatide) / AstraZeneca
NCT01235819: Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus

Checkmark P4 data
May 2012 - May 2012: P4 data
Checkmark P4 data
May 2012 - May 2012: P4 data
Completed
4
20
RoW
Insulin, Premixed Insulin, Sitagliptin, DPP 4 inhibitors, Exenatide, GLP 1 analogues
Command Hospital, India
Type 1 Diabetes
09/11
09/11
NCT01269047: Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

Completed
4
37
US
Pramlintide, Symlin, Exenatide, Byetta, Type 1 diabetes, Insulin, Novolog, Humalog, Levemir, Lantus
Albert Einstein College of Medicine, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes
08/16
12/16

Download Options